Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Liver Disease
75%
Alcohol Use
75%
Non-alcoholic Fatty Liver Disease (NAFLD)
75%
Mayo Clinic
75%
Integrated Therapy
75%
Alcoholic Hepatitis
52%
Hepatitis
25%
Clinical Trials
25%
Clinical Trials Network
25%
Translational Network
25%
Clinical Observational Study
25%
Prednisone
16%
Interleukin-22 (IL-22)
14%
Stopping Rule
14%
Acamprosate
14%
FDA-approved Drugs
13%
Motivational Interviewing
11%
Alcohol
9%
Interim Analysis
9%
Biosamples
9%
Liver
9%
Quality of Life
7%
Team Approach
7%
Treatment Seeking
7%
Caregivers
7%
Patient Outcomes
7%
F Protein
7%
Drug Therapy
7%
Knowledge Gaps
7%
Integrated Management
7%
Quality of Care Outcomes
7%
AUD Treatment
7%
Clinical Outcomes
7%
Clinical Impact
7%
Patient Registry
7%
Disease Condition
7%
Perceived Stigma
7%
Behavior Therapy
7%
Novel Therapies
7%
Patient Demographics
7%
90-day Mortality
7%
Behavioral Therapy
7%
Lille Score
7%
Ancillary
7%
Morbimortality
7%
Treatment Trials
7%
Fusion Protein
7%
Existing Resources
7%
Liver-related Mortality
7%
Poor Outcome
7%
Score-based
7%
Lille
7%
Lactobacillus Rhamnosus
5%
12-step Programs
5%
Randomized Controlled Trial
5%
Alcohol Misuse
5%
Trial Design
5%
Network Applications
5%
Limited Treatment Options
5%
SMART Trial
5%
Usual Care
5%
Anakinra
5%
Granulocyte Colony-stimulating Factor (G-CSF)
5%
Unified Treatment
5%
Medicine and Dentistry
Alcohol Consumption
100%
Liver Disease
100%
Hepatitis
22%
Morbidity
14%
Behavior Therapy
12%
Acamprosate
12%
Randomized Controlled Trial
10%
Prednisone
10%
Alcoholic Polyneuropathy
10%
Motivational Interviewing
9%
Patient Population
6%
Knowledge Gap
6%
Steroids
6%
Drug Therapy
6%
Interim Analysis
6%
Patient Registry
6%
Chimeric Protein
6%
Quality of Life
6%
Liver Cirrhosis
5%
Lactobacillus rhamnosus
5%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Disease
75%
Hepatitis
47%
Clinical Trial
25%
Alcohol Liver Disease
25%
Observational Study
25%
Prednisone
14%
Acamprosate
12%
Morbidity
12%
Randomized Controlled Trial
10%
Granulocyte Colony Stimulating Factor
6%
Steroids
6%
Pharmacotherapy
6%
Chimeric Protein
6%
Patient Registry
6%
Lactobacillus rhamnosus
5%
Liver Cirrhosis
5%
Anakinra
5%